HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.

10th Edition of International Conference on Neurology and Brain Disorders

October 21-23, 2024

October 21 -23, 2024 | Baltimore, Maryland, USA
INBC 2017

The application of human mesenchymal stem cell for alzheimer’s disease

Speaker at Neuroscience Conference - Jong Wook Chang
Samsung Medical Center, Korea, Republic of
Title : The application of human mesenchymal stem cell for alzheimer’s disease

Abstract:

Various groups have presented findings that human mesenchymal stem cells (MSCs) have both immunomodulatory and trophic properties. MSCs tend to act indirectly at sites of injury or damage through the secretion of paracrine factors in vitro & in vivo. For example, our studies have been done using a transgenic Alzheimer’s disease mouse model where intraparenchymal injections of MSCs resulted in the reduction of amyloid plaque levels, anti-apoptosis, activation of endogenous neural stem cell and also activate proteasome in neuron. In addition, efficient MSC delivery also is significant issue for human study. By possessing a broad range of functions, MSCs hold great potential in being used as a novel treatment for various diseases including neurodegenerative disorders.

Biography:

Will be Updated Soon...

Watsapp